23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

POWER: Combining Extensive Pleiotropy in the 23andMe Database and Computational Biology for Target Discovery Genetic insights GWAS signals / pleiotropy (one variant affecting multiple traits) disease 1 disease 2 disease 3 disease 4 signal 1 signal 2 signal 3 signal 4 signal 5 signal 6 Computational Biology ML / AI QTL-based and custom ML models for gene mapping and target hypothesis prioritization Interpretation of GWAS signals making extensive use of pleiotropy and allelic series and to increase reliability of biological conclusions Analysis of bulk/single cell/differential gene expression Biological insights genes, mechanisms, pathways and cell types Copyright © 2024 23and Me, Inc. JAK/STAT Th1/Th2 dif Recept int Th17 diff 23andMe 12
View entire presentation